Switzerland vs Tajikistan: Number of deaths from cardiovascular diseases by type
Switzerland
101 deaths
in 2021
Tajikistan
101.27 deaths
in 2021
Switzerland rank
101st
Tajikistan rank
100th
Number of deaths from cardiovascular diseases by type over time
- Switzerland
- Tajikistan
How they compare
Tajikistan currently reports 101.27 deaths against 101 deaths in Switzerland, a difference of 0.27 deaths.
The two have swapped places 5 times across 22 shared years of data; in 2000 it was Switzerland ahead.
Switzerland ranks 101st and Tajikistan ranks 100th of 194 countries.
Across the 3 decades both report, Switzerland averaged higher in 2 and Tajikistan in 1.
Head to head by decade
| Decade | Switzerland | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 118.01 deaths | 105.86 deaths | 12.15 deaths | Switzerland |
| 2010s | 82.24 deaths | 99.82 deaths | 17.58 deaths | Tajikistan |
| 2020s | 97.84 deaths | 95.81 deaths | 2.03 deaths | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of deaths from cardiovascular diseases by type, Switzerland or Tajikistan?
- Tajikistan, at 101.27 deaths against 101 deaths in Switzerland as of 2021.
- What is the difference in number of deaths from cardiovascular diseases by type between Switzerland and Tajikistan?
- 0.27 deaths, with Tajikistan ahead.
- How many years of comparable data are there for Switzerland and Tajikistan?
- 22 years are reported by both, from 2000 to 2021.
- How do Switzerland and Tajikistan rank globally for number of deaths from cardiovascular diseases by type?
- Switzerland ranks 101st and Tajikistan ranks 100th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Number of deaths from cardiovascular diseases by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from rheumatic heart disease in both sexes.